The Cooper Companies, Inc. $COO Shares Sold by Geode Capital Management LLC

Geode Capital Management LLC reduced its position in The Cooper Companies, Inc. (NASDAQ:COO) by 0.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 5,274,687 shares of the medical device company’s stock after selling 28,026 shares during the quarter. Geode Capital Management LLC’s holdings in Cooper Companies were worth $430,659,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in COO. Bell Investment Advisors Inc raised its stake in Cooper Companies by 106.3% in the 3rd quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock valued at $29,000 after purchasing an additional 219 shares during the last quarter. CYBER HORNET ETFs LLC acquired a new position in Cooper Companies in the 2nd quarter valued at $36,000. True Wealth Design LLC raised its stake in Cooper Companies by 484.8% in the 4th quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock valued at $38,000 after purchasing an additional 383 shares during the last quarter. Cromwell Holdings LLC raised its stake in Cooper Companies by 128.8% in the 4th quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock valued at $40,000 after purchasing an additional 273 shares during the last quarter. Finally, Board of the Pension Protection Fund acquired a new position in Cooper Companies in the 4th quarter valued at $41,000. 24.39% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

COO has been the subject of several recent research reports. The Goldman Sachs Group set a $61.00 price objective on Cooper Companies in a research note on Wednesday. Barclays increased their price objective on Cooper Companies from $98.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday, March 6th. Wall Street Zen raised Cooper Companies from a “hold” rating to a “buy” rating in a research note on Saturday, February 28th. Needham & Company LLC increased their price objective on Cooper Companies from $99.00 to $101.00 and gave the company a “buy” rating in a research note on Friday, March 6th. Finally, Rothschild & Co Redburn downgraded Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 target price for the company. in a research note on Wednesday, March 4th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $88.64.

Cooper Companies Price Performance

Shares of COO opened at $61.21 on Monday. The Cooper Companies, Inc. has a 52-week low of $58.89 and a 52-week high of $89.83. The company has a market capitalization of $11.94 billion, a PE ratio of 30.30, a price-to-earnings-growth ratio of 1.58 and a beta of 0.88. The stock has a fifty day simple moving average of $65.96 and a two-hundred day simple moving average of $74.89. The company has a quick ratio of 0.79, a current ratio of 1.34 and a debt-to-equity ratio of 0.22.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.03 by $0.07. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The business had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.02 billion. During the same period last year, the company earned $0.92 EPS. The company’s revenue for the quarter was up 6.2% on a year-over-year basis. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. As a group, equities analysts forecast that The Cooper Companies, Inc. will post 4.62 EPS for the current year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.